Drug Profile
FCE 28260
Alternative Names: PNU 156765Latest Information Update: 02 Aug 2002
Price :
$50
*
At a glance
- Originator Pharmacia Corporation
- Class Antineoplastics
- Mechanism of Action Cholestenone 5-alpha reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Benign prostatic hyperplasia; Prostate cancer